Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine ...

Many racetracks have succumbed to high real-estate prices in recent years, their sweeping turns or steep banking replaced by subdivisions or warehouses. At least for now, Virginia International ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the efficacy results hoped for in a midstage study. The investigational combo of ...

Find Vir Das Post Latest News, Videos & Pictures on Vir Das Post and see latest updates, news, information from NDTV.COM. Explore more on Vir Das Post.

ALTON, Va. (WFXR) – The VIRginia International Raceway (VIR) has announced this year is its 25th anniversary and is gearing up to celebrate with high-octane heart-pumping thrills all season.

HALIFAX COUNTY, Va. (WDBJ) - A core piece of history is growing at the Virginia International Raceway. Many people don’t tend to think about trees when they’re at a racetrack, but for VIR fans, that’s ...

- Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta on track to begin in the first half of 2025 - Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. However, VIR also pivoted to oncology, discontinuing vaccines and viral immunotherapy, and ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it has entered into an exclusive worldwide license agreement with Sanofi for three clinical-stage masked ...

Vir Das recently posted about the hills around Mumbai he happened to notice from a flight window. His video went viral and ...

Vir Das is back on the big screens with his directorial debut Hindi film 'Happy Patel'. Produced by Aamir Khan, the makers have finally released the film's trailer after a humorous announcement video ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program, despite their primary focus on hepatitis management. The company's market cap has surged past $1 billion, ...